Find a Research Expert

Experts
 Menu

Steven G Gray

Institution

Trinity College Dublin

Contact

Subjects

Biochemistry

Medicine & Nursing

Details
Publications 48
As first author 9
As last author 22
Unique topics 282
Collaborations 47
Sources 11
Are you Steven G Gray? Click here to provide feedback on your profile.
All
2019
2018
2017
2016
2015
2014
2013
2012
2011
Earlier
All
2019
2018
2017
2016
2015
2014
2013
2012
2011
Earlier

2019

Cost-Efficient and Easy to Perform PCR-Based Assay to Identify Met Exon 14 Skipping in Formalin-Fixed Paraffin-Embedded (FFPE) Non-Small Cell Lung Cancer (NSCLC) Samples
2018

BBI608 inhibits cancer stemness and reverses cisplatin resistance in NSCLC.
2018

Carcinogenesis in Prostate Cancer: The role of Long Non-Coding RNAs
2018

Cost-Efficient and Easy to Perform PCR-Based Assay to Identify Met Exon 14 Skipping in Formalin-Fixed Paraffin-Embedded (FFPE) Non-Small Cell Lung Cancer (NSCLC) Samples.
2018

Evaluation of NGS and RT-PCR Methods for ALK Rearrangement in European NSCLC Patients: Results from the European Thoracic Oncology Platform Lungscape Project
2018

In silico and in vitro analyses of lncRNAs as potential regulators in the transition from the epithelioid to sarcomatoid histotype of malignant pleural mesothelioma (MPM)
2018

RNAs as Candidate Diagnostic and Prognostic Markers of Prostate Cancer-From Cell Line Models to Liquid Biopsies.
2017

Carcinogenesis in prostate cancer: The role of long non-coding RNAs.
2017

Circular RNAs: Biogenesis, Function and Role in Human Diseases.
2017

Extraction and Quantification of Sinapinic Acid from Irish Rapeseed Meal and Assessment of Angiotensin-I Converting Enzyme (ACE-I) Inhibitory Activity.
2017

Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells.
2017

Sinapinic and Protocatechuic Acids Found in Rapeseed: Isolation, characterisation and potential benefits for human health as functional food ingredients
2017

Targeting the cancer stem cell marker, aldehyde dehydrogenase 1, to circumvent cisplatin resistance in NSCLC.
2016

Kdm6a and Kdm6b: Altered expression in malignant pleural mesothelioma.
2016

PD-L1 as a Companion Biomarker for Immune Checkpoint Inhibitors in NSCLC: Should RNA ISH (RISH) Be Considered?
2016

Promotion of a cancer-like phenotype, through chronic exposure to inflammatory cytokines and hypoxia in a bronchial epithelial cell line model.
2016

The IL-17-Th1/Th17 pathway: an attractive target for lung cancer therapy?
2015

Epigenetic Methodologies for the Study of Celiac Disease.
2015

Induction of protein citrullination and auto-antibodies production in murine exposed to nickel nanomaterials.
2015

KAT5 (Tip60) is a potential therapeutic target in malignant pleural mesothelioma.
2015

Lung cancer stem cells: The root of resistance.
2015

Non-coding RNA repertoires in malignant pleural mesothelioma.
2015

Promotion of a cancer-like phenotype, through chronic exposure to inflammatory cytokines and hypoxia in a bronchial epithelial cell line model.
2015

VEGF-mediated cell survival in non-small-cell lung cancer: implications for epigenetic targeting of VEGF receptors as a therapeutic approach.
2015

Vascular endothelial growth factor is an autocrine growth factor, signaling through neuropilin-1 in non-small cell lung cancer
2014

Long noncoding RNAs in liver cancer: what we know in 2014.
2014

The emerging role of microRNAs in resistance to lung cancer treatments.
2014

Vascular endothelial growth factor is an autocrine growth factor, signaling through neuropilin-1 in non-small cell lung cancer.
2013

Generation and characterisation of Cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signature.
2013

IL-23R is Epigenetically Regulated and Modulated by Chemotherapy in Non-Small Cell Lung Cancer.
2013

Long non coding RNAs (lncRNAs) are dysregulated in Malignant Pleural Mesothelioma (MPM).
2012

Gemcitabine reactivates epigenetically silenced genes and functions as a DNA methyltransferase inhibitor.
2012

Generation and characterisation of Cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signature.
2012

IL-23 is pro-proliferative, epigenetically regulated and modulated by chemotherapy in non-small cell lung cancer.
2012

Vorinostat eliminates multicellular resistance of mesothelioma 3D spheroids via restoration of Noxa expression.
2011

Epigenetic Regulation of Glucose Transporters in Non-Small Cell Lung Cancer
2011

Epigenetics Underpinning the Regulation of the CXC (ELR+) Chemokines in Non-Small Cell Lung Cancer
2011

IL-20 is epigenetically regulated in NSCLC and down regulates the expression of VEGF.
2011

Receptor tyrosine kinases and their activation in melanoma.
2011

The SGBS cell strain as a model for the in vitro study of obesity and cancer.
2011

The role of epigenetics in resistance to cisplatin chemotherapy in lung cancer
2010

Targeting oxidative stress in cancer.
2010

The role of epigenetics in resistance to Cisplatin chemotherapy in lung cancer.
2009

Histone deacetylase inhibitors target diabetes via chromatin remodeling or as chemical chaperones?
2009

NF-κB regulation: The nuclear response
2009

Oxidative stress induced lung cancer and COPD: opportunities for epigenetic therapy.
2008

Targeting histone deacetylases for the treatment of disease.
2007

Endoplasmic reticulum stress--a double edged sword for Z alpha-1 antitrypsin deficiency hepatoxicity.

These arethe11 unique sources for Steven G Gray's 48 publications. A single publication may appear in multiple sources. Click on a name or publication count to see the publications for a particular source.

Source #
Ireland -> Dublin Institute of Technology 4
Ireland -> Dublin Institute of Technology -> PubMed 4
Ireland -> Royal College of Surgeons in Ireland 2
Ireland -> Royal College of Surgeons in Ireland -> PubMed 1
Ireland -> TU Dublin 3
Ireland -> TU Dublin (Tallaght Campus) 1
Ireland -> TU Dublin (Tallaght Campus) -> PubMed 1
Ireland -> Trinity College Dublin 34
Ireland -> Trinity College Dublin -> PubMed 21
Ireland -> University College Dublin 4
Ireland -> University College Dublin -> PubMed 4

  1. Further insights

    Clicking through these tabs will give you a wealth of further insights into this expert through their commonly used topics, the evolution of their expertise, their collaborators and their publications.

  2. Details

    Here is a quick breakdown of this expert's publication history

  3. Contact

    If this is the expert you have been looking for, simply click here to make contact.